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Abstract
Background: Cancer mortality pattern in Ghana has not been reviewed since 1953, and there are
no population-based data available for cancer morbidity and mortality patterns in Ghana due to the
absence of a population-based cancer registry anywhere in the country.
Methods: A retrospective review of autopsy records of Department of Pathology, and medical
certificate of cause of death books from all the wards of the Korle-Bu Teaching Hospital (KBTH),
Accra, Ghana during the 10-year period 1991–2000 was done.
Results: The present study reviews 3659 cancer deaths at the KBTH over the 10-year period. The
male-to-female ratio was 1.2:1. The mean age for females was 46.5 [Standard Deviation (SD), 20.8]
years, whilst that of males was 47.8 (SD, 22.2) years. The median age was 48 years for females and
50 years for males.Both sexes showed a first peak in childhood, a drop in adolescence and young
adulthood, and a second peak in the middle ages followed by a fall in the elderly, with the second
peak occurring a decade earlier in females than in males. The commonest cause of cancer death in
females was malignancies of the breast [Age-Standardized Cancer Ratio (ASCAR), 17.24%],
followed closely by haematopoietic organs (14.69%), liver (10.97%) and cervix (8.47%). Whilst in
males, the highest mortality was from the liver (21.15%), followed by prostate (17.35%),
haematopoietic organs (15.57%), and stomach (7.26%).
Conclusion:  Considering the little information available on cancer patterns in Ghana, this
combined autopsy and death certification data from the largest tertiary hospital is of considerable
value in providing reliable information on the cancer patterns in Ghana.
Background
Knowledge of cancer patterns in Africa is woefully inade-
quate [1-7], and population-based epidemiological data
on the occurrence of cancer in sub-Saharan Africa, espe-
cially, are sparse. Until recently, cancers and other non-
communicable diseases were thought to be unimportant
public health problems in developing countries, like
Ghana, because of the overwhelming high prevalence of
communicable diseases. The previous studies have
focused on cancer morbidity data from the few estab-
lished cancer registries in Africa, with very few reporting
on cancer mortality data.
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Malignant neoplasms accounted for 914 (2.6%) of all
34,598 admissions, and 141 (5.6%) of all 2,501 deaths at
the Korle-Bu Teaching Hospital (KBTH) in the year
1996[8]. The case fatality risk from malignancies was thus
15.4%[8]. A review of the cancer register in the Depart-
ment of Child Health, KBTH, over a 40-month period
revealed that malignancies accounted for 1.67% of all
admissions, with lymphomas (mainly Burkitt's lympho-
mas) being the commonest tumour (67%),followed by
retinoblastoma (8.6%), leukaemia (8.2%) and Wilm's
tumour (7.8%)[9]. The above cancer morbidity trend in
the Ghanaian paediatric population is similar to the pic-
ture seen in West Africa and other developing African
countries [9-22], with the exception of Namibia[23].
Previous reviews of cancer in Ghana have been mainly
restricted to the study of single cancers, rather than the rel-
ative contributions of the various cancers to the disease
burden because of the absence of a population-based reg-
istry. One of such reviews of autopsy material at the KBTH
over the 10-year period from 1972–1981 (two decades
earlier than this study), with emphasis on carcinoma of
the pancreas, revealed that pancreatic cancers accounted
for 5.8% of all cancer deaths over that period[24]. There
has been no recent report on a systematic study of cancer
mortality pattern across all age groups in Ghana. The
problems of collecting cancer mortality statistics in devel-
oping countries have been described [1-7]. Knowledge of
cancer patterns in Africa have largely been based on hos-
pital series collected by clinicians and pathologists [1-7].
Despite the problems associated with interpreting data
from hospital-based series, they are an invaluable source
of information on cancer patterns where incidence and
mortality data are unavailable. Ghana is on the threshold
of starting a population-based cancer registry that will col-
lect data on both morbidity and mortality. It is therefore
an opportune time to attempt to present information on
cancer mortality pattern before the advent of the registry
to serve as the basis for future reference. This paper is
partly hospital-based data and partly community-derived
data to try and present as close a picture to the true situa-
tion as is possible now. This study was therefore carried
out to establish the relative contributions of the various
cancers to the cancer deaths certified and/or autopsied at
the Korle-Bu Teaching Hospital, Accra, Ghana over a
period of 10-years (1991–2000).
Methods
All cancer deaths diagnosed at autopsy in the 10-year
period from the beginning of January 1991 to the end of
December 2000 were retrieved from the autopsy logbooks
of the Department of Pathology, and all certified cancer
deaths for which medical certificates of cause of death
were issued in all the wards and units of the Korle-Bu
Teaching Hospital over the same period were also col-
lected and reviewed retrospectively to find all cancer
deaths seen from 1991 to 2000 inclusive. All cases were
entered into a database using the Paradox for workgroups
microcomputer software (Boreland International, Inc)
and later transferred into the EPI-INFO microcomputer
software version 3.3 (Centres for Disease Control, Atlanta,
USA.). Three thousand, six hundred and fifty-nine (3659)
cases were retrieved and reviewed. Information collected
on each case included the name, age, sex, date of death
and the site of the primary tumour. To avoid double enu-
meration of autopsied cases for which certificates of cause
of death were subsequently issued in the hospital, the
database programme was set up to reject any case that had
the same name, age, sex and site as an already registered
case until this had been proved to be an entirely new case.
The primary site and morphology data were coded using
the International Classification of Diseases (10th Edition,
ICD-10, World Health Organization)[25]. The ages were
grouped according to the format used by International
Agency for Research on Cancer (IARC, Lyon, France) for
cancer reporting [1-7], namely 0–14, 15–24, 25–34, 35–
44, 45–54, 55–64, and ≥65 years. Cases were analyzed
according to sex and age distribution for all cases, and sex
and age distribution for selected sites. The relative fre-
quency (RF)of different cancer types varies greatly in rela-
tion to the age group studied, and thus the proportion of
different cancers in a particular series is strongly influ-
enced by the age composition of the series. This poses a
problem when comparing summary statistics derived
from populations of different age structures[1]. To over-
come this problem and allow for comparison of propor-
tions derived from this study with those derived from case
series of different age structures, the age-standardized can-
cer ratio (ASCAR) was chosen as the standardization
method. The reference case standard distribution used to
calculate ASCAR was the standard age distribution of can-
cer cases for developing countries, namely 0–14 (5%),
15–24 (5%), 25–34 (5%), 35–44 (10%), 45–54 (20%),
55–64 (25%), and ≥ 65 (30%) years[1]. Tumours of the
skin were excluded in calculating the ASCARaccording to
convention [1-7]. The protocol for the study was
approved by the Ethical and Protocol Review Committee
of the University of Ghana Medical School, Accra, Ghana.
Results
There were 1651 (45.1%) females and 2008 (54.9%)
males in the series, making a total of 3659 cases. The male
to female ratio is thus 1.2:1. The mean age for females was
46.5 years (SD, 20.8) and that of males was 47.8 years
(SD, 22.2). The median age was 48 years for females and
50 years for males. The ages were not stated for 1 female
and 4 males. Both sexes showed a peak in childhood with
a drop in adolescence and young adulthood, and a rise to
another peak in the middle ages followed by a fall in theBMC Public Health 2006, 6:159 http://www.biomedcentral.com/1471-2458/6/159
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elderly. The second peak occurs a decade earlier in females
than in males.
The number of cases from each primary cancer site by age
group, the summary RFrates of these sites and the ASCAR
in females and males are shown in Tables 1 and 2, respec-
tively. In females, malignancies of the breast (ASCAR,
17.24%) are the commonest cause of deaths, followed by
the haematopoietic organs (lymphomas and leukaemias,
14.69%), and then the liver (10.97%), and the cervix
(8.47%). In males, the highest mortality is from the liver
(ASCAR, 21.15%), followed by the prostate (17.35%),
and the haematopoietic organs (15.57%), and the stom-
ach (7.26%). Deaths from tumours of the anus and eyes
are uncommon in both sexes, while deaths from laryngeal
cancers in female (ASCAR, 0.1%) are much less common
than in males (2.75%), and deaths from stomach cancers
in males (7.26%) are much more common than in
females (4.76%).
There were 375 children (< 15 years), of which 209
(55.7%) were males and 166 (44.3%) were females, giv-
ing a paediatric male to female ratio of 1.26:1. Figure 1
shows the gender distribution of the various sites involved
by tumours in children. In both sexes, the malignancies
with the highest mortalityare those of the haematopoietic
system, 57.8% of all paediatric cases in females and
60.3% among males. These are followed by brain and
renal tumours. Liver and eye tumours feature in the top six
death-causing malignancies in male children, but appear
to be of less importance among female children, while
bone tumours seem more important in female than male
children.
The number of females in the adolescent and young adult
age group (15–24 years) was 106 (42.7%), while males
were 142 in number (57.3%), giving a male to female
ratio of 1.3:1. Again, malignancies of the haematopoietic
system dominate the picture, causing 43.4% of cancer
deaths in females and 50.7% of the male cancer deaths.
These are followed in the females by brain and then
hepatic followed by ovarian tumours. In the males, hae-
matopoietic malignancies were followed by hepatic, bone
and brain tumours in that order. While in the children,
bone tumours appeared more important as a cause of
death in females than in males, in the adolescents and
young adults the converse is found. Tumours of the eye
continue to be more important in males than in female
adolescents and young adults, as they were in children. An
interesting finding is the occurrence of deaths due to
endometrial tumours in this young age group, all of which
were found to be due to choriocarcinoma, and the RF of
mortality from pancreatic tumours of 4.2% in males and
0% in females. In this series, these pancreatic tumours
occurred mainly in young adults (mean age 20 years).
Bladder cancers contributed to 1.4% of cancer deaths in
Table 1: Number of cases by age group and summary frequency rates in females
SITE ALL AGES 0–14 15–24 25–34 35–44 45–54 55–64 ≥ 65 RF % ASCAR
B R E A S T 2 8 3 0 4 1 98 98 25 3 3 6 1 7 . 1 1 7 . 2 4
HAMATOPOIETIC ORGANS 300 96 46 34 29 35 32 28 18.2 14.69
L I V E R 1 8 0 11 04 02 63 03 6 3 7 1 0 . 9 1 0 . 9 7
G A L L B L A D D E R 4 8 0 01369 2 9 2 . 9 3 . 8 4
PANCREAS 73 1 0 2 6 9 21 34 4.3 5.68
OESOPHAGUS 5 0 0 1 0 2 0 2 0.3 0.34
S T O M A C H 6 0 0 0329 1 3 3 3 3 . 6 4 . 7 6
COLON & RECTUM 64 0 0 5 8 14 12 25 3.9 4.59
ANUS 1 0 0 0 0 1 0 0 0.1 0.04
CERVIX 122* 0 0 5 24 27 36 29 7.4 8.47
ENDOMETRIUM 63 0 6 13 9 14 12 9 3.8 3.75
OVARY 100 3 7 7 23 18 24 18 6.0 6.32
BRAIN 77 19 11 14 9 8 7 9 4.7 3.76
NASOPHARYNX 14 3 5 1 0 4 1 0 0.8 0.71
L A R Y N X 2 0 00110 0 0 . 1 0 . 1 0
LUNG 37 1 2 5 4 8 5 12 2.2 2.43
B O N E 2 1 6 45231 0 1 . 3 0 . 8 8
K I D N E Y 3 9 1 6 11845 4 2 . 4 1 . 9 0
E Y E 1 0 4 03011 1 0 . 6 0 . 4 5
B L A D D E R 2 7 0 00566 1 0 1 . 6 1 . 9 8
SOFT TISSUE 28 5 3 2 8 3 0 7 1.7 1.46
O T H E R 9 7 1 17 1 01 31 51 8 2 3 5 . 9 5 . 6 7
ALL SITES 1651 166 106 171 269 300 292 346 100 100
* Age not stated for 1 caseBMC Public Health 2006, 6:159 http://www.biomedcentral.com/1471-2458/6/159
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male adolescents and young adults, but 0% in females of
the same age group. Conversely, soft tissue cancers con-
tributed to 2.8% of cancer deaths in female adolescents
and young adults, but 0% in males of the same age group.
The gender distribution of the RF of mortality from the
various primary cancer sites in older adults, including the
elderly, showed that the commonest fatal malignancies in
females are those arising in the breast, while in males
hepatic tumours are the commonest. Other gender differ-
ences in the pattern of cancer mortality in older adults that
clearly stand out include laryngeal tumours which are
about 27 times, oesophageal cancers which are about 6
times, and liver cancers which are about twice as common
in males as in females. Additionally, lung and bladder
cancers are about twice as common in male than female
older adults. Gallbladder cancers are 5 times commoner
in female than male older adults. The RF of pancreatic
cancer deaths are similar between male and female older
adults, in contrast to the 4.2% relative frequency in male
adolescents and young adults and 0% in females of that
age group.
Discussion
Cancer is a worldwide public health problem. It accounts
for 12.5% of all deaths, more than the percentage of
deaths caused by HIV/AIDS, tuberculosis and malaria put
together, is the second leading cause of death in devel-
oped countries, and is among the three leading causes of
death for adults in developing countries[26]. In 2002,
there were 6.7 million cancer deaths worldwide with less
than 5% of these in sub-Saharan Africa. It is estimated that
by 2020, cancer could kill 10.3 million people worldwide,
with a 50 to 75 percentage increase in cancer mortality in
sub-Saharan Africa[26]. This is the first report of cancer
mortality patterns in Ghana, since the report of Edington
in 1953[27]. The data used in the study were collected
from two sources, namely medical certificates of cause of
death issued in the hospital for deaths occurring in the
hospital and autopsy records of the Department of
Pathology of the hospital. Information from these sources
was combined in an attempt to overcome some of the bias
inherent in using data from either source. The Depart-
ment of Pathology carries out an average of 5,000 autop-
sies annually, the vast majority (75%) of which are
referred for autopsy by the coroner. Such coroner-referred
deaths normally occur in the community (outside any
hospital facility) or in the hospital usually in less than 24
hours of admission, when a firm cause of death would not
have been determined. However, all hospital-based data
on cancer are biased by selective factors that operate in
hospitals[1]. The hospital may not comprehensively cover
the population of interest. Thus hospital data may not
completely reflect what happens at the community level
as comparisons based on relative frequency of different
cancers in hospital-based series will be biased in terms of
the probability that the different cancers occurring in the
community will be included.
Table 2: Number of cases by age group and summary frequency rates in males
SITE ALL AGES 0–14 15–24 25–34 35–44 45–54 55–64 ≥65 RF % ASCAR
B R E A S T 1 2 0 01203 6 0 . 6 0 . 6 6
HAEMATOPOIETIC ORGANS 417 126 72 73 45 39 26 36 20.8 15.57
LIVER 428 10 19 82 98 96 65 58 21.3 21.15
G A L L B L A D D E R 1 2 0 10132 5 0 . 6 0 . 7 0
PANCREAS 91* 2 6 4 3 17 23 35 4.5 5.22
O E S O P H A G U S 3 9 0 0056 1 5 1 3 1 . 9 2 . 4 2
STOMACH 126** 1 1 7 7 21 30 57 6.3 7.26
C O L O N  &  R E C T U M 5 3 0 3468 1 1 2 1 2 . 6 2 . 9 5
A N U S 6 0 00121 2 0 . 3 0 . 3 6
BRAIN 67 18 9 7 11 6 7 9 3.3 2.78
N A S O P H A R Y N X 2 0 2 34162 2 1 . 0 0 . 9 3
L A R Y N X 4 5 * 0 0029 1 4 1 9 2 . 2 2 . 7 5
LUNG 78 1 2 6 5 18 22 24 3.9 4.56
B O N E 3 4 5 1 0 6533 2 1 . 7 1 . 3 5
PROSTATE 286 0 0 0 9 21 74 182 14.2 17.35
K I D N E Y 4 1 1 8 53127 5 2 . 0 1 . 6 3
BLADDER 91 1 2 7 12 23 14 32 4.5 5.07
E Y E 1 4 1 1 20010 0 0 . 7 0 . 4 0
S O F T  T I S S U E 1 9 4 04433 1 0 . 9 0 . 8 3
O T H E R 1 2 9 1 17 9 2 12 72 7 2 7 6 . 4 6 . 3 6
ALL SITES 2008 210 142 217 239 311 349 536 100 100
*Age not stated for 1 case.
** Age not stated for 2 casesBMC Public Health 2006, 6:159 http://www.biomedcentral.com/1471-2458/6/159
Page 5 of 7
(page number not for citation purposes)
Cancers are emerging as a significant health problem in
several parts of Africa[8,9,13-18], though infections
remain the leading cause of morbidity and mortality.
Indeed, cancers accounted for 2.6% of all admissions, and
5.6% of all deaths at the KBTH in the year 1996 [8]. In the
current study, malignancies of the breast were the leading
cause of deaths in females, followed closely by the hae-
matopoietic organs, liver and the cervix. In males, the
highest mortality was from the liver, followed closely by
the prostate, the haematopoietic organs and the stomach.
The relatively high position of liver, haematopoietic and
pancreas cancers in both sexes may be partly as a result of
their high case mortality rate in Ghana. A recent review of
cancer morbidity in adults in Ibadan, Nigeria showed
prostate cancer as the most common cancer in males,
whilst breast cancer topped the list in females[28]. The
first such review in the same population reported that can-
cers of the reticuloendothelial system topped the list[29],
while the second observed that liver cancer was common-
est among males and cervical cancer was commonest
among females[30]. Cancer mortality figures can be used
as a good approximation of incidence of cancers for which
mortality is high, such as hepatocellular carcinoma. Can-
cers with high survival rates will be underrepresented in
such series. Hospital autopsy series, although having good
diagnostic information, suffer from selective factors that
operate in causing admission to a hospital and in having
an autopsy. Thus they are not representative of deaths in a
population[1].
The International Agency for Research on Cancer (IARC)
has recently published GLOBOCAN 2002 estimates of
cancer incidence, mortality and prevalence for Ghana,
with the acknowledgement that the degree of detail and
quality of this source of data (both the accuracy of the
recorded cause of death and the completeness of the reg-
istration) vary considerably[26]. The GLOBOCAN 2002
estimates for Ghana are therefore a mixture of real data,
extrapolations from limited samples, and informed
guesses[26]. In contrast, this series is based on only actual
data and is the best contemporary information on the can-
cer mortality pattern in Ghana, though it is not derived
from a nationally-based cancer registry and therefore may
not be representative of the national cancer mortality pat-
tern.
GLOBOCAN 2002[26] reported that the top 10 causes of
cancer mortality in descending order in females in Ghana
were cervix, breast, liver, haematopoietic organs, stomach,
colorectal, ovary, bladder, with pancreas and Kaposi sar-
coma tied for the 9th and 10th position. In this series, the
top 10 causes of cancer mortality in descending order in
females in Ghana were breast, haematopoietic organs,
liver, cervix, ovary, pancreas, stomach, colorectal, gall
bladder and brain. Therefore, both GLOBOCAN and this
series concur that the top 4 causes of cancer deaths in Gha-
naian females are undoubtedly breast, cervix, haemat-
opoietic organs and liver, though cervix in 1st position for
GLOBOCAN was 4th in this series and haematopoietic
organs in 2nd position in this series was in 4th position for
GLOBOCAN for Ghanaian females.
GLOBOCAN 2002 [26]reported that the top 10 causes of
cancer mortality in descending order in males in Ghana
were prostate, liver, haematopoietic organs, colorectal,
bladder, Kaposi sarcoma, stomach, lung, larynx and oral
cavity. In this series, the top 10 causes of cancer mortality
in descending order in males in Ghana were liver, pros-
tate, haematopoietic organs, stomach, pancreas, bladder,
lung, colorectal, brain and larynx. Therefore, both GLOB-
OCAN and this series concur that the top 3 causes of can-
cer deaths in Ghanaian males are undoubtedly liver,
prostate and haematopoietic organs, with haematopoietic
cancers in 3rd position for both, and liver and prostate can-
cers swapping positions in the two series for Ghanaian
males.
In both sexes of Ghanaian children combined, themalig-
nancies with the highest mortality are those of the hae-
matopoietic system, followed by brain, kidney, eyes, liver
and bone tumours in that order. This cancer mortality pic-
ture is comparable to the reported cancer morbidity trend
in the Ghanaian paediatric population[9] and other
developing African countries [10-22], with a preponder-
ance of Burkitt's lymphomas, followed by retinoblast-
Gender distribution of cases in children Figure 1
Gender distribution of cases in children.
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oma, nephroblastoma and soft tissue sarcomas as the
commonest malignancies, and a low relative frequency of
leukaemias and intracranial tumours [9-22]. This is in
contrast to the situation in Europe and North America,
with their high leukaemia and intracranial tumour fre-
quency ratios, and low lymphoma frequency ratio. How-
ever, a report of frequency rates of childhood cancers in
Namibia, a developing African country, showed an inter-
mediate or mixed picture with tumours of the central
nervous system occurring most commonly (18%), fol-
lowed by renal tumours (14%), leukaemia (12%) and
lymphoma (11.5%)[23]. One obvious departure though,
is the second position of brain tumours in this paediatric
malignancy mortality series, compared to the low relative
frequency of intracranial tumours in most paediatric
malignancy morbidity series from developing African
counties [9-22], with the exception of Namibia[23]. The
reasons for these differences require further investigation,
though the high position of brain tumours in this mortal-
ity series may be as a result of its relatively higher case
mortality rate in Ghana, and thus its possible over-repre-
sentation in this mortality series.
Conclusion
The patterns observed from this study, despite the obvious
limitation of not being population-based, provide reliable
information on cancer mortality patterns in Ghana.
Whether the above observed patterns actually reflect par-
allel patterns in cancer morbidity and mortality in the
general Ghanaian population will have to await further
studies from the just established population-based cancer
registry in Accra, Ghana.
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